IBSA集团

2023年6月15日

。一起摩纳哥——(业务线)——# IBSA的摩纳哥王子阿尔伯特的高的赞助下,“自然运动奖2023”荣幸国际运动员致力于环境的保护,包括阿尔贝托·博纳(第八的位置在最后路线du Rhum和加勒比得主600 2023),Yohann Taberlet(获奖的法国残疾人滑雪),大卫·特雷泽盖(前足球运动员,世界冠军在1998年和2000年欧洲冠军)和一系列组织,对其具体承诺包容支持残疾人的航行。成立于2022年,这项运动对自然奖被分配到欧洲冠军的敏感性有优异表现的环境可持续性问题通过他们的行动和竞赛项目的相关行为,以及企业对环境表现出了同样的哲学。IBSA的奖项目驶入未来。分为两个部分,涉及:体育挑战,创新类40 IBSA: 6赛船会在2023年,多达13000英里穿越大西洋的比斯开湾,穿过英吉利海峡,凯尔特海和地中海,和结束越洋种族在马提尼克岛。但在体育上的挑战还引入了一个强有力的信息环境可持续性和对自然的尊重。IBSA运动的承诺-帆船作为手段来提高人们的包容和社会融合问题意识。包容性航行成为一个工具来克服身体和认知困难,教尊重他人,而反对偏见和歧视。今年的奖是授予IBSA制药,法国IBSA集团的子公司,包容性发展的航行计划。“在法国我们选择合作伙伴与昂蒂布游艇俱乐部支持主要包括航行计划。 In 2022, we donated two boats modified for children with disabilities, to involve them in experiences in close contact with the sea, allowing them to sail with accessible boats and to participate in integrated regattas. Our support will be renewed again this year, and will be even stronger, with the organisation of the first IBSA Regatta, specifically dedicated to children with disabilities between 12 and 17 years of age, which will take place on 29 and 30 September”, announced Fabrice Jover, CEO of IBSA Pharma in France. More info on: https://www.ibsasailing.com/en/ The Sport for Nature organisation. The association was created by Stefano Tirelli, professor of Complementary Sports Techniques at the Università Cattolica del Sacro Cuore and physical and mental trainer of several high-level athletes. In 2008, in Milan, he founded Studio Tirelli, a centre of excellence for Italian and international athletes. The organisation originates from the firm belief that high-level athletes have an exceptional power of communication with the younger generations. Its mission is to create an interactive and impactful relationship between sport and nature, in order to generate a positive change for our planet. The organisation aims to reduce our negative impact on the environment by promoting several sustainability initiatives for the Planet. IBSA (Institut Biochimique SA) is a Swiss multinational pharmaceutical Company, founded in 1945 in Lugano. Today, its products are present in over 90 Countries on 5 continents, through the Company’s 17 subsidiaries located in Europe, China, and the United States. The company has a consolidated turnover of 800 million CHF, and employs over 2,000 people between headquarters, subsidiaries and production sites. IBSA holds 90 families of approved patents, plus others under development, as well as a vast portfolio of products, covering 10 therapeutic areas: reproductive medicine, endocrinology, pain and inflammation, osteoarticular, aesthetic medicine, dermatology, uro-gynaecology, cardiometabolic, respiratory, consumer health. It is also one of the largest operators worldwide in the area of reproductive medicine, and one of the world’s leaders in hyaluronic acid-based products. IBSA has based its philosophy on four pillars: Person, Innovation, Quality and Responsibility. IBSA Pharma, managed by Fabrice Jover, is the French subsidiary of the Group, with offices in both Sophia Antipolis and Paris. Contacts